burger

A pharmaceutical company
specialising in biological
medicinal products

15 medicines

prescribed to

hospital

3 fields of therapy
  • Immunology
  • Haemostasis
  • Intensive Care
4

BIOPRODUCTION SITES in the world

2/3

of LFB’s biomedicinal products are intended for the treatment of patients with rare diseases

Group executive committee

Committee’s composition
€ 526.1 M in turnover

in 2023

1 of the leaders in France

IN THE FIELD OF PLASMA-DERIVED MEDICINAL PRODUCTS

All news

4:33

5th video episode of LFB Arras facility

5:31

Interview with Jacques Brom, June 2023

1:43

"The Powers of Blood" series: épisode 2 “What is Plasma?"

5:01

The fractionation of the LFB plasma-derived medicinal products : 1 plant on 2 sites

All videos

Extension of the indications of LFB's Von Willebrand coagulation factor in European Union

LFB acquires Amber Plasma in the Czech Republic and strengthens its plasma collection network in Europe

LFB PRESENTS ITS RAISON D’ÊTRE “LFB, expertise committed to life”

Strategic collaboration between LFB BIOMANUFACTURING and Sartorius.

Immerse yourself into the heart of LFB bioproduction site in Arras, 5th episode video

Doubling of LFB'S BIOPRODUCTION CAPACITY AT ALÈS WITH THE SUPPORT OF “FRANCE 2030”

LFB BIOMANUFACTURING JOINS FRANCE BIOLEAD

LFB bioproduction site in Alès: discover in pictures the multi-product industrial site

4:33

5th video episode of LFB Arras facility

there is 8 months

5:31

Interview with Jacques Brom, June 2023

there is 1 year

1:43

"The Powers of Blood" series: épisode 2 “What is Plasma?"

there is 2 years

5:01

The fractionation of the LFB plasma-derived medicinal products : 1 plant on 2 sites

there is 2 years